1. OPUS at UTS

Search

Current filters:
Add Filter:

Results

Customise results display
Item hits:
Issue DateTitleAuthor(s)
2023-02'What price do you put on your health?': Medical cannabis, financial toxicity and patient perspectives on medication access in advanced cancer.Olson, RE; Smith, A; Good, P; Dudley, M; Gurgenci, T; Hardy, J
2022-03Hypertonic packs to reverse blindness caused by facial lymphoedema in the setting of head and neck cancer - A case report.Gurgenci, T; Cree, R; Jessop, M; Lomas, J; Good, P
2023-03-01Phase IIb Randomized, Placebo-Controlled, Dose-Escalating, Double-Blind Study of Cannabidiol Oil for the Relief of Symptoms in Advanced Cancer (MedCan1-CBD).Hardy, J; Greer, R; Huggett, G; Kearney, A; Gurgenci, T; Good, P
2022-06-14Research agenda for medical cannabis in palliative care.Gurgenci, T; Hardy, J; Good, P
2023-06Medicinal cannabis in palliative medicine: lessons learnt from randomised controlled trials.Gurgenci, T; Hardy, J; Olson, R; Huggett, G; Foster, K; Good, P
2023-10-14Exploring potential anti-inflammatory effects of medicinal cannabis.Gurgenci, T; Kijanka, G; Greer, R; Huggett, G; Good, P; Moniruzzaman, M; Hardy, J
2024-05-30Correction: Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer-a study protocol for a randomised controlled trial.Gurgenci, T; Hardy, J; Huggett, G; Foster, K; Pelecanos, A; Greer, R; Philip, J; Haywood, A; Mendis, R; Yates, P; Good, P
2024-05-01Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer-a study protocol for a randomised controlled trial.Gurgenci, T; Hardy, J; Huggett, G; Foster, K; Pelecanos, A; Greer, R; Philip, J; Haywood, A; Mendis, R; Yates, P; Good, P
Results 1-8 of 8 (Search time: 0.095 seconds).
  • previous
  • 1
  • next

Discover